MMP9 and colorectal carcinoma: Studies using a 3D tumoroid model of metastatic CRC demonstrate that cisplatin and 5-FU, commonly used chemotherapeutics, stimulate MMP9 promoter activity within residual cancer cells, despite differing effects on overall tumor growth.